<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01351142</url>
  </required_header>
  <id_info>
    <org_study_id>CYTOCOGMA</org_study_id>
    <nct_id>NCT01351142</nct_id>
  </id_info>
  <brief_title>Cytokines and Cognitive Decline in Alzheimer's Disease</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <brief_summary>
    <textblock>
      Amyloid plaques and neurofibrillary tangles are the 2 well-known etiopathological hallmarks
      of Alzheimer's disease (AD). Beside these 2 lesions, inflammation response is described in
      the brain of patients with AD.

      The main objective of our study is to analyse the correlation between the value of plasma
      cytokines (interleukin 1, 6, TNFα and chemochine Rantes) and the rapidity of the cognitive
      decline in AD over a 2-year follow-up.

      Secondary objectives include:

        -  the predictive value of the cytokines on the cognitive decline after 6 months and one
           year of follow-up., of the patients include 150 patients with AD (MMSE: 16-25)

        -  correlation between plasma cytokines levels and expression of the protein kinase PKR
           (involved in death cell) in blood mononuclear cells.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
  </study_design_info>
  <enrollment type="Actual">133</enrollment>
  <condition>Alzheimer's Disease</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood test and cognitive tests</intervention_name>
    <description>Specific cognitive tests are performed at day 1, month 6, one year and 2 years Specific Blood samples tests are performed at inclusion, 1 years and 2 years</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Alzheimer's disease (AD)patients

          -  MMSE score: 16-25

          -  Written informed consent

        Exclusion Criteria:

          -  AD patients with specific treatment for AD before inclusion MMSE score under 16 or
             over 25 at inclusion

          -  patients with anti-inflammatory drugs (non steroids or corticosteroids) or
             immunosuppressive agents

          -  Patients with acute disease (infectious disease, rheumatologic disease) or chronic
             disease (malignancy, infectious, rheumatologic disease) that could interact with
             plasma cytokines level

          -  Patients with a life threatening disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Angers - service Gérontologie clinique</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Dupuytren - CHU de Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>MD</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de NANTES - service Gériatrie</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU DE NANTES - Centre ambulatoire de Gérontologie clinique</name>
      <address>
        <city>Nantes</city>
        <zip>44046</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Broca - service de Gériatrie</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Pitié Salpétrière</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu de Poitiers -</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67981</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de TOURS - service de Gériatrie</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital gériatrique des Charpennes</name>
      <address>
        <city>Villeurbanne</city>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2011</study_first_submitted>
  <study_first_submitted_qc>May 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2011</study_first_posted>
  <last_update_submitted>October 10, 2016</last_update_submitted>
  <last_update_submitted_qc>October 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 11, 2016</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

